234 related articles for article (PubMed ID: 27965123)
61. [Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
Starý J; Gajdos P; Blazek B; Ptoszková H; Mihál V; Pospísilová D; Hrstková H; Dembická D; Kopecná L; Slavík Z; Hak J; Procházková D; Zahálka F; Cerná Z; Jabali Y; Timr P; Vávra V; Mydlil J; Hrusák O; Trka J
Cas Lek Cesk; 2003; 142(7):404-9. PubMed ID: 14515443
[TBL] [Abstract][Full Text] [Related]
62. [The results of treatment by the Madrid Pediatric Oncology Group according to the BFM protocols in non-Hodgkin's B-cell lymphoma and acute B-cell lymphoblastic leukemia in pediatric patients].
Vivanco Martínez JL; García Gscheidle A; Cela de Julián ME; Torres Valdivieso MJ; Melero Moreno C; López Pérez J; Contra Gómez T; Martín Ramos N; Díaz Pérez MA; Bernácer Borja M; Gil López C; Valverde Moreno F
An Esp Pediatr; 1996 Jan; 44(1):11-6. PubMed ID: 8849052
[TBL] [Abstract][Full Text] [Related]
63. Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
Paganin M; Zecca M; Fabbri G; Polato K; Biondi A; Rizzari C; Locatelli F; Basso G
Leukemia; 2008 Dec; 22(12):2193-200. PubMed ID: 18754029
[TBL] [Abstract][Full Text] [Related]
64. [Mediastinal (thymic) large B-cell lymphoma: three cases reports].
Ji H; Zhang WY; Liu WP; Li GD; Li L
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):315-7. PubMed ID: 16181560
[No Abstract] [Full Text] [Related]
65. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
[TBL] [Abstract][Full Text] [Related]
66. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
Brodtman DH; Rosenthal DW; Redner A; Lanzkowsky P; Bonagura VR
J Pediatr; 2005 May; 146(5):654-61. PubMed ID: 15870670
[TBL] [Abstract][Full Text] [Related]
67. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
68. Non-Hodgkin malignant lymphoma revealed by an ovarian tumor case report and review of the literature.
Weingertner AS; Hamid D; Roedlich MN; Baldauf JJ
Gynecol Oncol; 2004 Dec; 95(3):750-4. PubMed ID: 15581998
[TBL] [Abstract][Full Text] [Related]
69. Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.
Aricò M; Conter V; Valsecchi MG; Rizzari C; Boccalatte MF; Barisone E; Messina C; De Rossi G; Lo Nigro L; Pession A; Locatelli F; Micalizzi C; Basso G
Haematologica; 2005 Sep; 90(9):1186-91. PubMed ID: 16154841
[TBL] [Abstract][Full Text] [Related]
70. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
Linker C; Damon L; Ries C; Navarro W
J Clin Oncol; 2002 May; 20(10):2464-71. PubMed ID: 12011123
[TBL] [Abstract][Full Text] [Related]
71. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
[TBL] [Abstract][Full Text] [Related]
72. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N
Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
[TBL] [Abstract][Full Text] [Related]
73. Ovarian relapse in a young woman with acute lymphoblastic leukaemia.
Heaton DC; Duff GB
Am J Hematol; 1989 Jan; 30(1):42-3. PubMed ID: 2910079
[TBL] [Abstract][Full Text] [Related]
74. T-Cell lymphoblastic lymphoma presenting as bilateral multinodular breast masses: a case report and review of the literature.
Vakiani E; Savage DG; Pile-Spellman E; El-Tamer M; Singh IR; Murty VS; Alobeid B; Bhagat G
Am J Hematol; 2005 Nov; 80(3):216-22. PubMed ID: 16247747
[TBL] [Abstract][Full Text] [Related]
75. Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
Rytting ME; Jabbour EJ; Jorgensen JL; Ravandi F; Franklin AR; Kadia TM; Pemmaraju N; Daver NG; Ferrajoli A; Garcia-Manero G; Konopleva MY; Borthakur G; Garris R; Wang S; Pierce S; Schroeder K; Kornblau SM; Thomas DA; Cortes JE; O'Brien SM; Kantarjian HM
Am J Hematol; 2016 Aug; 91(8):819-23. PubMed ID: 27178680
[TBL] [Abstract][Full Text] [Related]
76. Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Conter V; Schrappe M; Aricó M; Reiter A; Rizzari C; Dördelmann M; Valsecchi MG; Zimmermann M; Ludwig WD; Basso G; Masera G; Riehm H
J Clin Oncol; 1997 Aug; 15(8):2786-91. PubMed ID: 9256120
[TBL] [Abstract][Full Text] [Related]
77. Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.
Ducassou S; Ferlay C; Bergeron C; Girard S; Laureys G; Pacquement H; Plantaz D; Lutz P; Vannier JP; Uyttebroeck A; Bertrand Y
Br J Haematol; 2011 Feb; 152(4):441-51. PubMed ID: 21210776
[TBL] [Abstract][Full Text] [Related]
78. The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
Jabeen K; Ashraf MS; Iftikhar S; Belgaumi AF
J Pediatr Hematol Oncol; 2016 Nov; 38(8):587-596. PubMed ID: 27467375
[TBL] [Abstract][Full Text] [Related]
79. Can a blood test monitor lymphoma?
Jones K; Gandhi MK
Leuk Lymphoma; 2010 Jun; 51(6):957-9. PubMed ID: 20536342
[No Abstract] [Full Text] [Related]
80. [Lymphoproliferative disease following kidney transplantation].
Merkle M; Rupprecht HD
Dtsch Med Wochenschr; 2005 Jul; 130(28-29):1691-4. PubMed ID: 16003604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
